Showing posts with label CDC (Center for Disease Control). Show all posts
Showing posts with label CDC (Center for Disease Control). Show all posts

Sunday, November 2, 2014

Drinking a lot of milk doubled the risk of death for women, and increased hip fractures by 60%

Milk causes osteoporosis? How many trillions to we pay for medical care in the US? Why did we need to wait for a tiny country like Sweden to give us this information?

For years doctors prescribed large doses of Vitamin D and calcium that turned out to be no help at all with osteoporosis. All that time, our doctors never warned us against milk.

And the medical establishment moans about its helplessness in the face of Alzheimer's, but forgot to mention that D-galactose was associated with memory loss in animals in research going back to 2006. Certainly, my doctors never mentioned it.

Is our health being held hostage to the profits of politically-powerful groups like the milk lobby? It seems like every month I am presented with a new reason for not trusting the CDC (Center for Disease Control). It seems that the research done by the government too often involves increasing or protecting profits for some powerful, wealthy group of people. New drugs, new devices, new procedures keep coming down the pipeline. But of course, the people who repair broken hips aren't going to make as much money now that women have this information from Sweden.


Drinking a lot of milk may be shortening women’s lives
October 30, 2014
By Karen O’Shea
Irish Examiner

Drinking three or more glasses of milk per day may be harmful to women’s health, a study suggests.
Women in the study who drank at least three glasses of milk a day were nearly twice as likely to die over the next 20 years compared with their peers who drank less than a glass daily, researchers in Sweden found. In addition, the study, published in the British Medical Journal found that women’s risk of bone fracture climbed steadily as their milk intake increased.

The reason could be galactose, a simple sugar found in milk, said Karl Michaelsson, a professor at Uppsala University in Sweden and one of the study’s authors. “That compound might induce oxidative stress and low-grade inflammation, and that type of inflammation can affect mortality and fractures,” Michaelsson said. 

Many health bodies recommend that adults get the equivalent of three cups of milk daily, based on the idea that dairy is good for the bones, and may reduce heart disease risk. But there’s actually little scientific evidence to support these recommendations, the study authors said.

The study included 61,433 women who were ages 39 to 74 at the study’s start, and 45,339 men ages 45 to 79. The women were followed for 20 years, on average. During that time, 15,541 died and 17,252 had fractures, including 4,259 hip fractures. After the researchers took into account factors like age, body mass index and alcohol consumption, they found that women who drank three or more glasses of milk daily were 1.93 times more likely to die during the follow-up period than those who drank less than a glass of milk daily. 

Among the men, who were followed for an average of 11 years, there was no association between mortality or fractures and milk consumption. 

But dairy lovers need not despair. The researchers found that fermented milk products, like cheese and yogurt, which contain little or no galactose, had the opposite effect: women who ate or drank the most fermented milk products were less likely to die or sustain fractures during the study.



 http://www.bmj.com/content/349/bmj.g6015

Milk intake and risk of mortality and fractures in women and men: cohort studies

  • Accepted 22 September 2014

Abstract

Objective To examine whether high milk consumption is associated with mortality and fractures in women and men.
Design Cohort studies.
Setting Three counties in central Sweden.
Participants Two large Swedish cohorts, one with 61 433 women (39-74 years at baseline 1987-90) and one with 45 339 men (45-79 years at baseline 1997), were administered food frequency questionnaires. The women responded to a second food frequency questionnaire in 1997.
Main outcome measure Multivariable survival models were applied to determine the association between milk consumption and time to mortality or fracture.
Results During a mean follow-up of 20.1 years, 15 541 women died and 17 252 had a fracture, of whom 4259 had a hip fracture. In the male cohort with a mean follow-up of 11.2 years, 10 112 men died and 5066 had a fracture, with 1166 hip fracture cases. In women the adjusted mortality hazard ratio for three or more glasses of milk a day compared with less than one glass a day was 1.93 (95% confidence interval 1.80 to 2.06). For every glass of milk, the adjusted hazard ratio of all cause mortality was 1.15 (1.13 to 1.17) in women and 1.03 (1.01 to 1.04) in men. For every glass of milk in women no reduction was observed in fracture risk with higher milk consumption for any fracture (1.02, 1.00 to 1.04) or for hip fracture (1.09, 1.05 to 1.13). The corresponding adjusted hazard ratios in men were 1.01 (0.99 to 1.03) and 1.03 (0.99 to 1.07). In subsamples of two additional cohorts, one in males and one in females, a positive association was seen between milk intake and both urine 8-iso-PGF2α (a biomarker of oxidative stress) and serum interleukin 6 (a main inflammatory biomarker).

Conclusions High milk intake was associated with higher mortality in one cohort of women and in another cohort of men, and with higher fracture incidence in women. Given the observational study designs with the inherent possibility of residual confounding and reverse causation phenomena, a cautious interpretation of the results is recommended.

Introduction

A diet rich in milk products is promoted to reduce the likelihood of osteoporotic fractures. Milk contains 18 of 22 essential nutrients, including calcium, phosphorus, and vitamin D of especial importance for the skeleton. Intestinal uptake of these nutrients is enhanced by the enzymatic capacity to digest lactose into D-glucose and D-galactose by mutation in the lactase gene, a variant common in those with northern European ancestry.1 2 An intake of dairy foods corresponding to three or four glasses of milk a day has been suggested to save at least 20% of healthcare costs related to osteoporosis.3

A high intake of milk might, however, have undesirable effects, because milk is the main dietary source of D-galactose. 

Experimental evidence in several animal species indicates that chronic exposure to D-galactose is deleterious to health and the addition of D-galactose by injections or in the diet is an established animal model of aging.4 5 6 7 Even a low dose of D-galactose induces changes that resemble natural aging in animals, including shortened life span caused by oxidative stress damage, chronic inflammation, neurodegeneration, decreased immune response, and gene transcriptional changes.5 7 A subcutaneous dose of 100 mg/kg D-galactose accelerates senescence in mice.5 This is equivalent to 6-10 g in humans, corresponding to 1-2 glasses of milk. Based on a concentration of lactose in cow’s milk of approximately 5%, one glass of milk comprises about 5 g of D-galactose. The increase of oxidative stress with aging and chronic low grade inflammation is not only a pathogenetic mechanism of cardiovascular disease and cancer in humans8 9 but also a mechanism of age related bone loss and sarcopenia.9 10 The high amount of lactose and therefore D-galactose in milk with theoretical influences on processes such as oxidative stress and inflammation makes the recommendations to increase milk intake for prevention of fractures a conceivable contradiction.


  1. Karl Michaëlsson, professor1,
  2. Alicja Wolk, professor2,
  3. Sophie Langenskiöld, senior lecturer3,
  4. Samar Basu, professor3,
  5. Eva Warensjö Lemming, researcher14,
  6. Håkan Melhus, professor5,
  7. Liisa Byberg, associate professor1
    Author affiliations
  1. Correspondence to: K Michaëlsson karl.michaelsson@surgsci.uu.se

Monday, June 23, 2014

Exclusive: CDC reassigns director of lab behind anthrax blunder

Exclusive: CDC reassigns director of lab behind anthrax blunder

Jun 23, 2014
(Reuters)

The U.S. Centers for Disease Control and Prevention has reassigned the director of the bioterror lab behind the potential anthrax exposure of dozens of scientists and staff, sources told Reuters, as the anthrax controversy intensified.
Michael Farrell, head of the CDC's Bioterror Rapid Response and Advanced Technology Laboratory, has been reassigned as the agency investigates the incident, two CDC scientists who are not authorized to speak with press told Reuters.
The possible exposure has forced as many as 84 employees at the agency's Atlanta campus to get a vaccine or take powerful antibiotics with known side effects to ward off potentially deadly anthrax disease.
CDC spokesman Tom Skinner declined to comment on Farrell. Calls and e-mail to Farrell were not returned.
On Friday, the CDC gathered staff at a meeting, where individuals in labs adjacent to the affected areas complained they had not been properly informed about the anthrax incident first discovered on June 13, Skinner said.
In a Friday e-mail to staff, CDC Director Dr Thomas Frieden apologized for delays in informing the wider CDC community about lapses in the high-profile bioterror lab.
"We waited too long to inform the broader CDC workforce," he wrote in the email obtained by Reuters.
According to the CDC, some time between June 6 and June 13, workers in the bioterror lab were trying out a new protocol for killing anthrax before sending the bacteria for use in two lower-security CDC labs.
CDC spokesman Skinner on Sunday said the bioterror lab sent the anthrax bacteria to other labs in closed tubes. The recipients agitated the tubes and then removed the lids, raising concerns that live anthrax could have been released into the air.
Both of the CDC scientists Reuters spoke with believe the risk of infection is very slight because only a tiny amount of anthrax was sent out of the bioterror lab.
On June 18, a team of CDC scientists used swabs and wipes to take samples from all lab surfaces that might have been contaminated.
Skinner said results from the first two days of tests have been negative, but the CDC will continue watching the samples for another six days to see if anything grows.
Dr. Paul Meechan, director of the CDC's environmental health
and safety compliance office, first disclosed the possible
anthrax exposure to Reuters on Thursday.
(Editing by Peter Henderson)

Friday, June 13, 2014

It looks like the US government is no longer letting the cattlemen control the handling of mad cow disease

Federal and state food agencies have been mighty lenient with the cattlemen for years now, apparently waiting until enough Americans with mad cow disease had time to develop symptoms.  It can take as many as ten or twenty years for the disease to show up.

Just last November the USDA relaxed rules for importing cattle from areas known to harbor the disease.  (See second story below.)

Recently, the CDC admitted that a fourth American has died of mad cow disease.

Now, the USDA is finally getting off its duff. 

Over four thousand pounds of beef recalled

The United States Department of Agriculture announced a recall for over four thousand pounds of beef products that may be contaminated with mad cow disease.
A part of the nervous system that can be detrimental to consumers in cattle over a certain age is required to be completely removed from the beef. It is suspected that this regulation was not met precisely.
Fruitland American Meat, a company based in Missouri, informed consumers that the bone-in ribeye roasts were sold to a New York City restaurant, as well as a Whole Foods distribution center in Connecticut which provides for several of the New England stores, reports the Los Angeles Times.
There have been no reported incidents of any negative reactions to ingestion of these beef products. The USDA classified the incident as a low health risk.
The Food Safety and Inspection Service discovered the issue while reviewing the company’s slaughter logs. The USDA stated that the possible contamination might have been caused by the employees’ failure to properly determine the age of cattle.


USDA Eases Regulations on Beef Imports in Regard to ‘Mad Cow Disease’

The U.S. Department of Agriculture released its final ruling late Friday afternoon easing regulations on beef imports in regard to bovine spongiform encephalopathy (BSE), the fatal disease in cattle also known as “Mad Cow Disease.”
The new rule will bring the United States’ stance on beef imports in line with international standards that base trade policies on the scientifically perceived risk of animals or animal products harboring the disease, according to the USDA’s Animal and Plant Health Inspection Service (APHIS).
While the agency said the move modernizes the U.S.’s beef import regulations, some industry and consumer groups have come out against the new rules, saying they needlessly endanger U.S. consumers and the country’s cattle population.
Under the new rule, some current restrictions on beef imports will be lifted based on countries that have a “negligible risk for BSE,” a status determined by the World Organization for Animal Health (OIE). Commodities that pose more than a negligible risk may still be restricted, but not necessarily.
The rules could potentially reopen beef imports to the U.S. from the European Union, which have been restricted since 1998. The U.S. imports about 8.1 percent of its beef supply, predominantly in the form of live cattle from Canada and Mexico. About 10 percent of the U.S. beef supply is exported, mostly in the form of high quality cuts.
The move to align its BSE standards with international policies may also open U.S. beef exports to more foreign markets. In May, the OIE upgraded the status of U.S. BSE risk from “controlled” to “negligible,” the safest possible classification.
As an example of how the rule would change imports, the USDA said that boneless beef could be imported from countries that have had cases of BSE as boneless beef presents a scientifically negligible risk of transmitting BSE. Most imports have previously been prohibited from any country that had an indigenous case of BSE.
“These actions will further demonstrate to our trading partners our commitment to international standards and sound science,” the agency wrote in a fact sheet, “and we are hopeful it will help open new markets and remove remaining restrictions on U.S. cattle and cattle products.”
In a statement, National Cattlemen’s Beef Association (NCBA) President Scott George said the rule would be integral to expanding international beef trade and called it “great news for the U.S. cattle industry.”
Bill Bullard, president of rancher trade group R-CALF, disagreed, saying that the USDA’s new rule “radically” relaxed import restrictions for areas where BSE continues to persist.
Bullard pointed out that the European Union reported four new cases of BSE in 2013, saying that the new rule “opens the door to allow U.S. meatpackers to begin supplementing tight U.S. beef supplies with beef of questionable safety from Europe.”
Europe has reportedly detected 83 new cases of BSE since 2010, a significant reduction from past decades. Since the 1980s, the United Kingdom has seen more than 180,000 cases.
Bullard said the new rule also underscored the need for country-of-origin labeling laws, which are opposed by the NCBA and members of Congress via the 2013 Farm Bill.
The new rule could put both consumers and the U.S. cattle herd at risk, according to Dr. Michael Hansen, senior staff scientist at Consumers Union.
Hansen cited a recent study that found roughly one in 2,000 people in the U.K. were silent carriers of variant Creutzfeldt-Jakob disease (vCJD), the human form of BSE.
At least 177 U.K. citizens – and 49 other people around the world – have died from vCJD since 1996. One death has occurred in the past two years in the U.K., the country recognized as having the largest exposure to BSE, according to the BBC.
Humans can contract vCJD from eating meat contaminated with brain or spinal tissue from cattle infected with BSE. The agent that transmits BSE is not destroyed in the cooking process.
Countries around the world have tried to severely control the spread of BSE since its appearance in the 1980s. The disease began spreading through the practice of mixing cattle meat and bone meal into the feed of cattle herds.
BSE causes the brain and spinal cords of cattle to deteriorate. Symptoms typically appear in cattle older than 30 months.
The U.K. has seen more than 180,000 cases of BSE in cattle, by far the most of any country. By comparison, France and Portugal have each seen roughly 900, the second most. The U.S. has had four cases.
In the U.S. and other countries regulating BSE, cattle feed can no longer contain meat of other ruminant animals. USDA runs a surveillance program for BSE, and slaughterhouses are required to remove the brains and spinal cords from all carcasses.
USDA will file the new beef import rule in the Federal Register in the coming days. It takes effect 90 days from the filing date.


Monday, June 9, 2014

CDC confirms 4th U.S. case of mad cow disease after Texas man dies

Mad cow disease is still here, it turns out.  But is it really this rare?  Is it possible that some cases have been misdiagnosed?

CDC confirms 4th U.S. case of mad cow disease after Texas man dies

by Ryan Parker
Los Angeles Times
June 6, 2014

Mad cow disease -- the fourth confirmed case in the U.S. -- is responsible for the death of a Texas man, the Centers for Disease Control and Prevention said Friday.

The variant CJD, as it’s medically known, was confirmed by experts after a sample of the man’s brain tissue was analyzed.

No specifics on the victim or when he died were released.

“The history of this fourth patient, including extensive travel to Europe and the Middle East, supports the likelihood that infection occurred outside the United States,” the CDC said in a statement.

The disease is a rare, degenerative fatal brain disorder in humans that is believed to be caused by eating the meat of cows with the disease bovine spongiform encephalopathy, according to the CDC.
The disease in humans is more prevalent in Europe. The majority are in Britain, which has had 177 confirmed cases since the disease was discovered there in 1996, and France, with 27, the CDC reports.

Wednesday, October 10, 2012

Meningitis warning for those who've had spinal injections of steroids since May 21, 2012

Doctors have been having problems recognizing fungal meningitis.

Doctors Are Off Balance as Patients Show Atypical Meningitis Reactions
By JENNIFER CORBETT DOOREN
Wall Street Journal
October 10, 2012

The rare fungal meningitis behind a deadly national outbreak is difficult to diagnose because it can cause strokes and other reactions unlike those typically seen with the more common type of the illness.

Meningitis, a swelling of the protective membranes of the brain and spinal cord, is typically caused by bacteria that can be treated with antibiotics, or by a virus, for which there is no treatment.

Fungal meningitis, on the other hand, needs to be treated with antifungal drugs. The length of treatment isn't known but the federal Centers for Disease Control and Prevention is telling doctors that patients may need treatment for months.

Bacterial meningitis tends to attack quickly with a fever, a headache that grows worse, a stiff neck and eventually a loss of consciousness.

However, some patients who contracted fungal meningitis in the current outbreak have had just a mild headache and no fever, and "for the most part symptoms occur in a more gradual fashion," said William Schaffner, an infectious disease expert and chairman of the department of preventive medicine at Vanderbilt University School of Medicine in Nashville, which has treated four patients with fungal meningitis.

Dr. Schaffner said fungal meningitis is invading blood vessels and causing strokes in some patients affected by the current outbreak. But doctors don't typically test for meningitis when patients go to the emergency room with signs of stroke, such as weakness or loss of movement on one side of their bodies, slurred speech or sudden vision changes.

"Nobody is totally sure what these patients look like," said Trish Perl, senior hospital epidemiologist at the Johns Hopkins Health System in Baltimore, who is advising doctors about patients who might have the disease.

Because the fungal-meningitis symptoms have been so varied among patients, federal health officials have urged doctors to set a low bar in deciding whether to test patients who received a steroid injection in their backs. The test requires a spinal tap, which involves a needle inserted in the spinal column to collect spinal fluid.

The CDC has said as many as 13,000 people in 23 states have been exposed to the potentially contaminated steroid injections made by the New England Compounding Center before the products were recalled Sept. 26.
Compounding pharmacies create blends of medicines, including liquid forms of pills.

The agency said patients who have had an epidural steroid injection since May 21, 2012, and are experiencing symptoms such as headache, fever, sensitivity to light, slurred speech or numbness, should contact their doctors as soon as possible.

Officials are most concerned about spinal injections. Those given in other places, such as the knees or hips, are highly unlikely to cause meningitis, though there is the possibility of a local joint infection...